Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s
- 31 December 1995
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (4) , 549-552
- https://doi.org/10.1016/0959-8049(95)00061-m
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A novel ligand for CD44 is sulfated proteoglycanInternational Immunology, 1994
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.The Journal of Experimental Medicine, 1993
- Human RAG2, like RAGI, is on chromosome II band p13 and therefore not linked to ataxia telangiectasia complementation groupsGenes, Chromosomes and Cancer, 1992
- Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.The Journal of cell biology, 1992
- Distinct effects of two CD44 isoforms on tumor growth in vivo.The Journal of Experimental Medicine, 1991
- Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with MycScience, 1991
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- CD44 — A molecule involved in leukocyte adherence and T-cell activationImmunology Today, 1989
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984